Frank Laukien, Bruker’s President and CEO, commented: “We are pleased with our first quarter 2012 results, as we delivered 13.7% organic revenue growth, along with double-digit growth in operating income and net income year-over-year. Our backlog continued to grow even further due to excellent first quarter 2012 orders. The tone in many of our end markets has improved since the fourth quarter of 2011, and our focus on new products and innovative solutions for major secular trends in the life and materials sciences and related industries is resulting in excellent, profitable organic growth.”
I also liked this... "For the first quarter of 2012, Bruker’s cash flow provided by operations was $4.8 million, compared to cash used in operations of ($29.4) million in the first quarter of 2011."
BRKR closed yesterday (02012.04.30) at $15.03.
No comments:
Post a Comment